Quantitative proteomic analysis of trypsin-treated extracellular vesicles to identify the real-vesicular proteins.

Extracellular vesicles contaminated non-vesicular proteins exosomesproteomics trypsin/protease ultracentrifuge

Journal

Journal of extracellular vesicles
ISSN: 2001-3078
Titre abrégé: J Extracell Vesicles
Pays: United States
ID NLM: 101610479

Informations de publication

Date de publication:
2020
Historique:
received: 25 06 2019
revised: 23 01 2020
accepted: 10 04 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 4 6 2020
Statut: epublish

Résumé

Extracellular vesicles (EVs) are nano-sized vesicles surrounded by a lipid bilayer and released into the extracellular milieu by most of cells. Although various EV isolation methods have been established, most of the current methods isolate EVs with contaminated non-vesicular proteins. By applying the label-free quantitative proteomic analyses of human colon cancer cell SW480-derived EVs, we identified trypsin-sensitive and trypsin-resistant vesicular proteins. Further systems biology and protein-protein interaction network analyses based on their cellular localization, we classified the trypsin-sensitive and trypsin-resistant vesicular proteins into two subgroups: 363 candidate real-vesicular proteins and 151 contaminated non-vesicular proteins. Moreover, the protein interaction network analyses showed that candidate real-vesicular proteins are mainly derived from plasma membrane (46.8%), cytosol (36.6%), cytoskeleton (8.0%) and extracellular region (2.5%). On the other hand, most of the contaminated non-vesicular proteins derived from nucleus, Golgi apparatus, endoplasmic reticulum and mitochondria. In addition, ribosomal protein complexes and T-complex proteins were classified as the contaminated non-vesicular proteins. Taken together, our trypsin-digested proteomic approach on EVs is an important advance to identify the real-vesicular proteins that could help to understand EV biogenesis and protein cargo-sorting mechanism during EV release, to identify more reliable EV diagnostic marker proteins, and to decode pathophysiological roles of EVs.

Identifiants

pubmed: 32489530
doi: 10.1080/20013078.2020.1757209
pii: 1757209
pmc: PMC7241501
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1757209

Subventions

Organisme : NCI NIH HHS
ID : R01 CA218526
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA234557
Pays : United States

Informations de copyright

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of The International Society for Extracellular Vesicles.

Références

J Extracell Vesicles. 2013 Mar 19;2:
pubmed: 24009897
Nat Cell Biol. 2010 Jan;12(1):19-30; sup pp 1-13
pubmed: 19966785
Nat Biotechnol. 2014 Mar;32(3):223-6
pubmed: 24727771
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Trends Cell Biol. 2006 Jul;16(7):370-5
pubmed: 16769213
Trends Cell Biol. 2000 Aug;10(8):322-8
pubmed: 10884684
Cell Signal. 2011 Feb;23(2):317-23
pubmed: 20727968
Biochem Biophys Res Commun. 2010 Jun 25;397(2):251-6
pubmed: 20529672
Mol Cell Proteomics. 2008 Apr;7(4):631-44
pubmed: 18029349
Sci Rep. 2016 Nov 08;6:36338
pubmed: 27821849
Methods Mol Biol. 2015;1295:167-77
pubmed: 25820722
Nat Biotechnol. 2007 Jan;25(1):117-24
pubmed: 17187058
J Extracell Vesicles. 2012 Sep 11;1:
pubmed: 24009881
J Biochem. 2006 Jul;140(1):13-21
pubmed: 16877764
BMC Genomics. 2009 Nov 25;10:556
pubmed: 19930720
Nucleic Acids Res. 2012 Jan;40(Database issue):D1241-4
pubmed: 21989406
Mass Spectrom Rev. 2015 Jul-Aug;34(4):474-90
pubmed: 24421117
Semin Cell Dev Biol. 2015 Apr;40:97-104
pubmed: 25704309
Curr Biol. 2009 Dec 1;19(22):1875-85
pubmed: 19896381
Exp Cell Res. 2009 Jul 1;315(11):1953-63
pubmed: 19328198
J Extracell Vesicles. 2013 Dec 23;2:
pubmed: 24376909
Proteomics. 2015 Oct;15(19):3331-7
pubmed: 26201501
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
EMBO J. 2001 May 15;20(10):2443-53
pubmed: 11350933
PLoS Biol. 2012;10(12):e1001450
pubmed: 23271954
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
Cancer Lett. 2014 Aug 28;351(1):23-9
pubmed: 24858024
Cancer Res. 2009 Jul 1;69(13):5601-9
pubmed: 19549916
J Proteome Res. 2010 Nov 5;9(11):5698-704
pubmed: 20812748
Bioinformatics. 2015 Mar 15;31(6):933-9
pubmed: 25388151
J Leukoc Biol. 2007 Jan;81(1):15-27
pubmed: 16931602
Annu Rev Immunol. 1998;16:89-109
pubmed: 9597125
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Oncogene. 2012 Nov 8;31(45):4740-9
pubmed: 22266864
Proteomics. 2013 May;13(10-11):1554-71
pubmed: 23401200
J Proteome Res. 2012 Feb 3;11(2):1144-51
pubmed: 22149170

Auteurs

Dongsic Choi (D)

Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.
Research Institute of the McGill University Health Centre, Glen Site, McGill University, Montreal, Canada.

Gyeongyun Go (G)

Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.

Dae-Kyum Kim (DK)

Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.

Jaewook Lee (J)

Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.

Seon-Min Park (SM)

Pohang Center for Evaluation of Biomaterials, Pohang, Republic of Korea.

Dolores Di Vizio (D)

Department of Surgery, Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Yong Song Gho (YS)

Department of Life Sciences, Pohang University of Science and Technology, Pohang, Republic of Korea.

Classifications MeSH